Banks turn towards US lev deals for opportunities
Banks are looking to US deals to put money to work, with a $2bn term loan backing the takeover of IMS Health, the pharmaceutical intelligence provider, expected to have a $750m equivalent euro carve-out.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
